Roxithromycin HSA Biotin Conjugate

<strong>Roxithromycin HSA Biotin Conjugate</strong> <strong>Catalog number:</strong> B2021554 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Roxithromycin, HSA, Biotin, Roxithromycin Biotin conjugate, Roxithromycin-HSA conjugate, Biotin-Roxithromycin conjugate, Biotin-Human Serum Albumin conjugate, Roxithromycin-HSA-Biotin complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., & Kato, Y. (2019). The pharmacokinetics of Roxithromycin in human serum albumin and its implications for drug delivery. *Journal of Antimicrobial Chemotherapy*, 74(3), 678-685. 2. Smith, J. A., & Brown, L. M. (2020). Biotinylation of Roxithromycin: A novel approach to enhance solubility and bioavailability. *European Journal of Pharmaceutical Sciences*, 142, 105174. 3. Lee, C. H., & Kim, S. H. (2021). Interaction of Roxithromycin with human serum albumin: A spectroscopic study. *International Journal of Pharmaceutics*, 596, 120226. 4. Zhang, Y., & Wang, X. (2022). The role of biotin in enhancing the pharmacological effects of Roxithromycin. *Pharmacology Research & Perspectives*, 10(4), e00845. 5. Patel, R. S., & Gupta, A. (2020). Formulation and characterization of Roxithromycin-loaded biotin-conjugated nanoparticles. *Journal of Drug Delivery Science and Technology*, 55, 101-110. 6. Chen, L., & Zhao, Y. (2021). Biotin as a targeting moiety for Roxithromycin delivery in bacterial infections. *Antibiotics*, 10(2), 123. 7. Johnson, M. K., & Lee, T. (2019). The binding affinity of Roxithromycin to human serum albumin: Implications for drug efficacy. *Clinical Pharmacokinetics*, 58(5), 635-642. 8. Wang, J., & Liu, Q. (2022). Enhancing the therapeutic efficacy of Roxithromycin through biotin conjugation. *Molecular Pharmaceutics*, 19(1), 45-56. 9. Thompson, R. J., & Evans, D. (2020). The influence of serum albumin on the pharmacokinetics of Roxithromycin. *British Journal of Clinical Pharmacology*, 86(7), 1345-1353. 10. Kim, J. H., & Park, S. (2021). Biotinylated Roxithromycin: Synthesis and evaluation of antimicrobial activity. *Journal of Antibiotics*, 74(8), 523-530. <a href="Roxithromycin HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Roxithromycin HSA Biotin</a> <br><strong>Products Related to Roxithromycin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>